| Paul D Lyons, MD PHD | |
|
125a Medical Cir, Winchester, VA 22601-3322 | |
| (540) 667-1828 | |
| (540) 722-6207 |
| Full Name | Paul D Lyons |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 24 Years |
| Location | 125a Medical Cir, Winchester, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083656250 | NPI | - | NPPES |
| 001846010 | Other | VA | MOUNTAIN STATE BCBS |
| 010267749 | Medicaid | VA | |
| 196652 | Other | VA | ANTHEM BCBS |
| P00349162 | Other | VA | RAILROAD MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Winchester Medical Center | Winchester, VA | Hospital |
| Warren Memorial Hospital | Front royal, VA | Hospital |
| Shenandoah Memorial Hospital | Woodstock, VA | Hospital |
| Hampshire Memorial Hospital | Romney, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley Physician Enterprise Inc | 9931268091 | 205 |
News Archive
Cardiovascular Systems, Inc. has received FDA approval to complete enrollment of 429 patients in its ORBIT II Investigational Device Exemption clinical trial for a coronary application for its Diamondback 360 System.
Caraco Pharmaceutical Laboratories, Ltd., has announced that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Glipizide/Metformin Hydrochloride Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg (Glipizide/Metformin HCl).
A unique and richly detailed long-term study of survivors of severe critical illness requiring intensive care found that even those who were previously healthy, young and working did not regain the physical or psychological health they had before their illness.
States are grappling with budget crises and lost revenues that have affected health programs.
Health Robotics today announced that after a successful first year of cooperation in Japan with Tosho Inc., the companies signed this week a contract renewal of the CytoCare and i.v.STATION exclusive distribution agreements, and an expansion of their strategic relationship to include future joint-development projects in their respective areas of Pharmacy Automation expertise.
› Verified 8 days ago
| Entity Name | Winchester Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679711261 PECOS PAC ID: 0244134021 Enrollment ID: O20031124000061 |
News Archive
Cardiovascular Systems, Inc. has received FDA approval to complete enrollment of 429 patients in its ORBIT II Investigational Device Exemption clinical trial for a coronary application for its Diamondback 360 System.
Caraco Pharmaceutical Laboratories, Ltd., has announced that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Glipizide/Metformin Hydrochloride Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg (Glipizide/Metformin HCl).
A unique and richly detailed long-term study of survivors of severe critical illness requiring intensive care found that even those who were previously healthy, young and working did not regain the physical or psychological health they had before their illness.
States are grappling with budget crises and lost revenues that have affected health programs.
Health Robotics today announced that after a successful first year of cooperation in Japan with Tosho Inc., the companies signed this week a contract renewal of the CytoCare and i.v.STATION exclusive distribution agreements, and an expansion of their strategic relationship to include future joint-development projects in their respective areas of Pharmacy Automation expertise.
› Verified 8 days ago
| Entity Name | Valley Physician Enterprise Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538316203 PECOS PAC ID: 9931268091 Enrollment ID: O20081104000278 |
News Archive
Cardiovascular Systems, Inc. has received FDA approval to complete enrollment of 429 patients in its ORBIT II Investigational Device Exemption clinical trial for a coronary application for its Diamondback 360 System.
Caraco Pharmaceutical Laboratories, Ltd., has announced that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Glipizide/Metformin Hydrochloride Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg (Glipizide/Metformin HCl).
A unique and richly detailed long-term study of survivors of severe critical illness requiring intensive care found that even those who were previously healthy, young and working did not regain the physical or psychological health they had before their illness.
States are grappling with budget crises and lost revenues that have affected health programs.
Health Robotics today announced that after a successful first year of cooperation in Japan with Tosho Inc., the companies signed this week a contract renewal of the CytoCare and i.v.STATION exclusive distribution agreements, and an expansion of their strategic relationship to include future joint-development projects in their respective areas of Pharmacy Automation expertise.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul D Lyons, MD PHD 125 Medical Cir, Suite A, Winchester, VA 22601-3300 Ph: (540) 667-1828 | Paul D Lyons, MD PHD 125a Medical Cir, Winchester, VA 22601-3322 Ph: (540) 667-1828 |
News Archive
Cardiovascular Systems, Inc. has received FDA approval to complete enrollment of 429 patients in its ORBIT II Investigational Device Exemption clinical trial for a coronary application for its Diamondback 360 System.
Caraco Pharmaceutical Laboratories, Ltd., has announced that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Glipizide/Metformin Hydrochloride Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg (Glipizide/Metformin HCl).
A unique and richly detailed long-term study of survivors of severe critical illness requiring intensive care found that even those who were previously healthy, young and working did not regain the physical or psychological health they had before their illness.
States are grappling with budget crises and lost revenues that have affected health programs.
Health Robotics today announced that after a successful first year of cooperation in Japan with Tosho Inc., the companies signed this week a contract renewal of the CytoCare and i.v.STATION exclusive distribution agreements, and an expansion of their strategic relationship to include future joint-development projects in their respective areas of Pharmacy Automation expertise.
› Verified 8 days ago
Megan Kathryn Borkon, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 214 S Braddock St, Winchester, VA 22601 Phone: 540-535-2448 Fax: 405-535-7287 | |
Andrew Denis Mccarthy, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1830 Amherst St, Winchester, VA 22601 Phone: 540-667-1828 Fax: 540-722-6207 | |
Edward S Kurz, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8000 Fax: 540-536-7681 | |
Dr. Mark A Landrio, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 905 Cedar Creek Grade, Suite 200, Winchester, VA 22601 Phone: 540-722-8882 Fax: 540-722-8883 | |
Dr. James Robert Lizer, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 335 Westside Station Dr, Winchester, VA 22601 Phone: 540-662-7555 Fax: 540-662-9105 | |
Dr. Shabana Firdous, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1812 Plaza Dr, Winchester, VA 22601 Phone: 540-667-1226 Fax: 540-667-0519 |